drugset / Trial / NCT06784336
Phase II Study of Resistant Potato Starch Plus Deferasirox to Improve Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation
NaSingle-groupOpen-labelTreatment
Summary
The study will evaluate the safety and early efficacy of administering the combination of a commercially available potato-based resistant starch along with iron chelation therapy to subjects undergoing alloHCT.
Timeline
- Start
- 2025-10-15
- Primary completion
- 2028-10
- Completion
- 2029-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Deferasirox | Unknown | 7 mg/kg | — |
| Subject | Deferasirox | Unknown | 10 mg/kg | — |
| Subject | Potato Resistant Starch | Other / unclassified | 20 g | — |